Parents Continue to File Zofran Lawsuits

Written by admin

More than 280 Zofran lawsuits are pending in the U.S. District Court; District of Massachusetts. Plaintiffs from all over the nation filling lawsuit against Zofran alleging that the drug to treat morning sickness during Pregnancy can lead to newborns having cleft palate, cardiac malformations and kidney malfunctions. Recently two more cases of zofran birth defects have been filed and transferred to the US District Court of Massachusetts. As per the complaints of the parents from Mississippi and Texas, the drug is associated with major birth defects. These two new cases join the 280 cases which are pending in the U.S. District Court; District of Massachusetts, a total of 282 lawsuits against Zofran manufacturer, the multi-national healthcare giant GlaxoSmithKline, have been consolidated in the Boston federal court for pre-trial proceedings. The lawsuits allege that GlaxoSmithKline’s failure to adequately warn about the potential Zofran side effects on unborn babies.

A recent Zofran lawsuit was filed on behalf of a mother from Petal, Mississippi who gave birth to a child with severe births defects including skeletal muscle atrophy and cardiomegaly, an abnormally enlarged heart. The mother lists no less than 13 severe symptoms and numerous congenital abnormalities. The lawsuit filed as a Short Form complaint on 12th of October; it was initially filed in the US District Court for the Southern District of Texas. The lawsuit is registered in the Zofran Multi-District Litigation with the other lawsuits pending in the court.  According to the court document the child name is K.W and she is now three years old. The lawsuit clearly outlines the devastating effects that Zofran allegedly have on pregnant women and their children. Parents claim that during early pregnancy Ondansetron can cause severe Congenital Malformations on the fetus.

The second lawsuit was filed in Texas on 12th of October this year. According to the lawsuit, a mother from Katy, Texas alleges that Zofran medication caused her unborn child to develop cardiac septal defects. The woman stated that the child was born with two specific “hole in the heart” abnormalities, atrial septal defect and ventricular septal defect. She claims that manufacturer failed to determine safety risks before selling Zofran and did not have safety concern before offering the drug to the public. As per Danish researchers Zofran’s active ingredient, a chemical known as ondansetron could boost the risk for cardiac septal defects by 200% to 400%. The Fertility Centers of New England warns women not to take Zofran during pregnancy.

Zofran has been given an FDA rating of “Pregnancy Category B.”. Pregnancy Category B indicates that the medication has not been proven safe for uses in pregnancy but many women have been prescribed Zofran for morning sickness. Medical practice guidelines advice It is illegal for physician to prescribe an off label medication for unapproved uses and without proper clinical testing. If you or someone you know took Zofran and had a baby born with cleft palate, cardiac malformations, kidney malfunctions and other severe Congenital Malformations, please contact for a free case review. Our experience attorney’s team are dedicated to protecting consumers through individual litigation, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.




About the author


Leave a Comment